12Jan 2025
Oral Vancomycin in IBD-PSC Treatment

Oral Vancomycin in IBD-PSC Treatment

This systematic review and pooled analysis evaluated the effectiveness of oral vancomycin therapy (OVT) in treating IBD associated with primary sclerosing cholangitis (IBD-PSC). Among 290 patients, OVT resulted in a clinical response in 47.6% and clinical remission in 43.5%. Biochemical remission was observed in 68.8% and endoscopic remission in 39.4%. OVT showed a favorable safety profile, but further trials are needed for definitive recommendations on dosing and long-term safety.

  • #gastroenterology

Like

Save

Share